MEDcraze LLC Announces $3 Million Seed Financing to Launch its New Patient-Driven Medical Technology Platform

MEDcraze LLC, an online platform startup that provides patient information and access to new medical technologies, announced today the completion of a 3 million seed round. This seed financing has been made exclusively by JG Griffeth Investments LLC.

MEDcraze LLC, an online platform startup that provides patient information and access to new medical technologies, announced today the completion of a 3 million seed round. This seed financing has been made exclusively by JG Griffeth Investments LLC.

The company will use the proceeds to make key hires and continue to build out additional platform features. Most importantly, it will kickstart advertising efforts and opportunities for medical device, biotech and pharmaceutical companies that have recently launched new products.

“This capital will be instrumental in helping us scale MEDcraze and will serve our mission of creating awareness of new technologies that address an individual’s particular medical circumstance,” said Carey Markey, MEDcraze’s Founder and CEO.  “We are absolutely devoted to providing medical companies a cost-effective method of obtaining mass exposure for their respective technologies. At MEDcraze, we create a win-win. Patients benefit by easily accessing information on newly released products that address their diagnosis and/or surgical procedure and medical companies benefit by getting great exposure of their product offering,” added Manny Trujillo MD, Plastic Surgeon and Co-Founder of MEDcraze.

About JG Griffeth Investments LLC

JG Griffeth Investments LLC is a private holding company that specializes primarily in commercial healthcare real estate developments. JG Griffeth Investments has invested in MEDcraze because of the exciting prospects it brings to patient empowerment and to broaden and diversify its investment portfolio.

About MEDcraze LLC

Headquartered in Atlanta GA, MEDcraze is a unique online community built by Patients, Clinicians and Industry. If you have been recently diagnosed, or have an upcoming surgical procedure, you can now obtain access to applicable advancements in medical technology. You can then take this information and have an elevated discussion, based on technology, with your healthcare provider.

For more information, please visit us at www.medcraze.com.

Media Contact, Carey Markey, 678-360-1689, info@medcraze.com

Total
0
Shares
Leave a Reply
Related Posts
Read More

Clark Atlanta University, Augusta University Partner on Cyber-Security and Cyber-Physical Systems

December 3, 2019 – Clark Atlanta University (CAU) and Augusta University (AU) announced that they have forged a partnership between the CAU Department of Cyber-Physical Systems and the School of Computer and Cyber Sciences at Augusta University. The partnership was announced at a press event held at Comcast-NBC Universal’s tech accelerator, the Farm in Atlanta.
Read More

Digital Matter and Helium Announce Partnership to Simplify Asset Tracking via Nationwide Peer-to-Peer IoT Network

Digital Matter, a global leader in GPS and IoT hardware development, today announced a partnership with Helium, the company behind one of the world's first peer-to-peer wireless networks. Through the partnership, the companies will now work together to enable Digital Matter's portfolio of GPS and IoT tracking devices that work for a range of applications to be fully integrated on Helium's IoT Network, The People's Network.
Read More

BioIQ Expands Return-to-Office Support Ecosystem to Help Employers Navigate COVID-19 Testing, Legal, and Workspace Considerations

BioIQ, a healthcare engagement and clinical adherence technology platform company, has partnered with Cresa and Ogletree Deakins to help employers navigate the many practical and legal issues to consider when crafting a workplace COVID-19 testing and return-to-work strategy. The BioIQ return-to-work ecosystem is designed to move employers up the learning curve quickly and expedite efforts to reopen the US economy.